首页> 外文期刊>Indian Journal of Pharmaceutical Education & Research >Design and Synthesis of Novel Indolizine Analogues as COX-2 Inhibitors: Computational Perspective and in vitro Screening
【24h】

Design and Synthesis of Novel Indolizine Analogues as COX-2 Inhibitors: Computational Perspective and in vitro Screening

机译:作为COX-2抑制剂的新型吲嗪类似物的设计与合成:计算透视和体外筛选

获取原文
获取原文并翻译 | 示例
           

摘要

Design and synthesis of a new series of ethyl 7-methoxy-2-substituted-3-(substituted benzoyl) indolizine-1-carboxylates 2a-i was achieved and screened for their in vitro inhibitory activity against COX-2 enzyme. Compound 2a and 2c emerged as promising COX-2 enzyme inhibitor with IC50 of 6.56 and 6.94 mu M respectively from the synthesized series when compared to Celecoxib and Indomethacin as selective and nonselective standards, respectively. Computational docking study identified the possible reasons for such activity that may be due to the cis configuration of the indolizines that resulted in the most stable conformation similar to that of Indomethacin.
机译:达到新的7-甲氧基-2-取代-3-(取代的苯甲酰基)吲嗪-1-羧酸酯2A-1的设计和合成,并筛选其对COX-2酶的体外抑制活性。 与Celecoxib和Indomethacin相比,分别与合成系列分别作为有选择性和非选择性标准的合成系列的合成系列具有6.56和6.94μm的有前途的COX-2酶抑制剂。 计算对接研究确定了这种活动的可能原因,这可能是由于吲哚的CIS构型,导致与吲哚美辛相似的最稳定的构象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号